panobinostat

Definition of panobinostat lactate
National Cancer Institute

panobinostat lactate

(PA-noh-BIH-noh-stat LAK-tayt)
A drug used with bortezomib and dexamethasone to treat multiple myeloma. It is used in patients whose cancer has already been treated with at least two other therapies, including bortezomib and an immunomodulating agent. It is also being studied in the treatment of other types of cancer. Panobinostat lactate blocks certain enzymes, which may help keep cancer cells from growing and dividing and may kill them. It may also prevent the growth of new blood vessels that tumors need to grow. Panobinostat lactate is a type of histone deacetylase inhibitor and a type of antiangiogenesis agent. Also called Farydak and LBH589.

Source: NCI Dictionary of Cancer Terms